RU95108547A - Бензолалкановые кислоты, промежуточные соединения, способ получения, фармацевтическая композиция - Google Patents

Бензолалкановые кислоты, промежуточные соединения, способ получения, фармацевтическая композиция

Info

Publication number
RU95108547A
RU95108547A RU95108547/04A RU95108547A RU95108547A RU 95108547 A RU95108547 A RU 95108547A RU 95108547/04 A RU95108547/04 A RU 95108547/04A RU 95108547 A RU95108547 A RU 95108547A RU 95108547 A RU95108547 A RU 95108547A
Authority
RU
Russia
Prior art keywords
alkyl
ris
production
pharmaceutical composition
intermediate compounds
Prior art date
Application number
RU95108547/04A
Other languages
English (en)
Other versions
RU2110512C1 (ru
Inventor
Питер Дикинсон Роджер
Gb]
Нейл Дэк Кевин
Стил Джон
Original Assignee
Пфайзер Рисерч энд Дивелопмент Компани
Пфайзер Рисерч энд Дивелопмент Компани, Эн.Ви./Эс.Эй.
Эн.Ви./Эс.Эй. (IE)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Рисерч энд Дивелопмент Компани, Пфайзер Рисерч энд Дивелопмент Компани, Эн.Ви./Эс.Эй., Эн.Ви./Эс.Эй. (IE) filed Critical Пфайзер Рисерч энд Дивелопмент Компани
Publication of RU95108547A publication Critical patent/RU95108547A/ru
Application granted granted Critical
Publication of RU2110512C1 publication Critical patent/RU2110512C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Соединения общей формулы, приведенной в описании, и их фармацевтически приемлемые соли и биолабильные эфиры являются антагонистами тромбоксана A, их применяют, в частности, в комбинации с ингибитором тромбоксансинтетазы для лечения атеросклероза и нестабильной стенокардии и для предотвращения реокклюзии после чрескожной пластической операции на сосудах.

Claims (1)

  1. Соединения общей формулы, приведенной в описании, и их фармацевтически приемлемые соли и биолабильные эфиры являются антагонистами тромбоксана A2, их применяют, в частности, в комбинации с ингибитором тромбоксансинтетазы для лечения атеросклероза и нестабильной стенокардии и для предотвращения реокклюзии после чрескожной пластической операции на сосудах.
RU95108547A 1992-09-23 1993-09-14 Производные бензолалкановой кислоты и фармацевтическая композиция RU2110512C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9220137.5 1992-09-23
GB929220137A GB9220137D0 (en) 1992-09-23 1992-09-23 Therapeutic agents
PCT/EP1993/002488 WO1994006761A1 (en) 1992-09-23 1993-09-14 Benzenealkanoic acids for cardiovascular diseases

Publications (2)

Publication Number Publication Date
RU95108547A true RU95108547A (ru) 1997-02-10
RU2110512C1 RU2110512C1 (ru) 1998-05-10

Family

ID=10722399

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95108547A RU2110512C1 (ru) 1992-09-23 1993-09-14 Производные бензолалкановой кислоты и фармацевтическая композиция

Country Status (29)

Country Link
US (1) US5618941A (ru)
EP (1) EP0662950B1 (ru)
JP (1) JP2625262B2 (ru)
KR (1) KR0169182B1 (ru)
CN (1) CN1037176C (ru)
AT (1) ATE162184T1 (ru)
AU (1) AU666976B2 (ru)
BR (1) BR9307091A (ru)
CA (1) CA2145296C (ru)
CZ (1) CZ72095A3 (ru)
DE (1) DE69316380T2 (ru)
DK (1) DK0662950T3 (ru)
EG (1) EG20285A (ru)
ES (1) ES2111176T3 (ru)
FI (1) FI114862B (ru)
GB (1) GB9220137D0 (ru)
GR (1) GR3025909T3 (ru)
HU (1) HUT70512A (ru)
IL (1) IL106993A (ru)
MX (1) MX9305843A (ru)
MY (1) MY109576A (ru)
NO (1) NO302698B1 (ru)
NZ (1) NZ255412A (ru)
PL (1) PL174431B1 (ru)
RU (1) RU2110512C1 (ru)
TW (1) TW283704B (ru)
WO (1) WO1994006761A1 (ru)
YU (1) YU60993A (ru)
ZA (1) ZA936961B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2444513C2 (ru) * 2006-03-28 2012-03-10 Каро Био Аб Улучшенный кристаллический материал

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2265996A1 (en) 1996-09-26 1998-04-02 Roger Aki Fujimoto Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US5986136A (en) * 1997-04-15 1999-11-16 President And Fellows Of Harvard College Photolabeling reagent
DE10059418A1 (de) * 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
FR2827280B1 (fr) * 2001-07-13 2003-10-31 Servier Lab Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003244913A1 (en) * 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
CN1318507C (zh) * 2003-03-04 2007-05-30 陈少岳<Del/> 一种水晶树脂及其生产方法
US20050059741A1 (en) * 2003-08-07 2005-03-17 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
DE102004007358B4 (de) * 2004-02-16 2017-10-12 Chiron As Kongenere, chlorierte, bromierte und/oder iodierte, fluorierte aromatische Verbindungen mit zwei Benzolringen in ihrer Grundstruktur, Verfahren zu ihrer Herstellung und ihre Verwendung
EA200701745A1 (ru) * 2005-03-17 2008-06-30 Пфайзер, Инк. Циклопропанкарбоксамидные производные
WO2009089098A1 (en) 2008-01-03 2009-07-16 Musc Foundation For Research Development Methods for the treatment of cancers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
DE68909958D1 (de) * 1988-01-19 1993-11-25 Tanabe Seiyaku Co Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung.
DE3819052A1 (de) * 1988-06-04 1989-12-07 Basf Ag Neue sulfonamid-derivate, ihre herstellung und verwendung
GB9107043D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Therapeutic agents
TW219358B (ru) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2444513C2 (ru) * 2006-03-28 2012-03-10 Каро Био Аб Улучшенный кристаллический материал

Also Published As

Publication number Publication date
AU4960093A (en) 1994-04-12
ES2111176T3 (es) 1998-03-01
FI951341A0 (fi) 1995-03-22
ATE162184T1 (de) 1998-01-15
NO302698B1 (no) 1998-04-14
MX9305843A (es) 1995-01-31
JPH08502046A (ja) 1996-03-05
DE69316380D1 (de) 1998-02-19
NO951080D0 (no) 1995-03-21
TW283704B (ru) 1996-08-21
PL308144A1 (en) 1995-07-24
BR9307091A (pt) 1999-03-30
IL106993A0 (en) 1993-12-28
FI114862B (fi) 2005-01-14
CN1087080A (zh) 1994-05-25
WO1994006761A1 (en) 1994-03-31
HUT70512A (en) 1995-10-30
CZ72095A3 (en) 1995-07-12
MY109576A (en) 1997-02-28
NZ255412A (en) 1996-09-25
GB9220137D0 (en) 1992-11-04
KR950704242A (ko) 1995-11-17
ZA936961B (en) 1995-03-22
GR3025909T3 (en) 1998-04-30
DK0662950T3 (da) 1998-02-09
RU2110512C1 (ru) 1998-05-10
EP0662950B1 (en) 1998-01-14
DE69316380T2 (de) 1998-04-30
AU666976B2 (en) 1996-02-29
FI951341A (fi) 1995-03-22
YU60993A (sh) 1997-07-31
EG20285A (en) 1998-07-30
CA2145296A1 (en) 1994-03-31
JP2625262B2 (ja) 1997-07-02
KR0169182B1 (ko) 1999-03-20
EP0662950A1 (en) 1995-07-19
IL106993A (en) 1997-06-10
HU9500838D0 (en) 1995-05-29
CN1037176C (zh) 1998-01-28
NO951080L (no) 1995-03-21
US5618941A (en) 1997-04-08
CA2145296C (en) 2002-01-29
PL174431B1 (pl) 1998-07-31

Similar Documents

Publication Publication Date Title
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
ATE238280T1 (de) Verwendung eines pharmazeutisch geeigneten salzes von (3r,2&#39;r)-3-((cyclopentyl- hydroxyphenylacetyl)oxy)-1,1-dimethyl- pyrrolidinium zur herstellung eines arzneimittels
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
RU95108547A (ru) Бензолалкановые кислоты, промежуточные соединения, способ получения, фармацевтическая композиция
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
RU94034115A (ru) Конденсированные циклические соединения и ингибиторы сквален-синтетазы
ATE235459T1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
NO20024772L (no) Percyquinnin, fremgangsmÕte for dets fremstilling og dets anvendelse som et legemiddel
NO301880B1 (no) Substituerte heterocykliske karboksylsyreamider og deres anvendelse for fremstilling av legemidler
WO1999047497A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
RU94035686A (ru) 4-ариламино-бензопиран и родственные соединения, фармацевтическая композиция, способ лечения
RU94037247A (ru) Применение гетероциклических соединений для снижения содержания холестерина в сыворотке крови
EA200401108A1 (ru) Соли толтеродина
AU3181789A (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
ES2091183T3 (es) Metodo para mejorar el sueño.
RU94046047A (ru) Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли
HUP0102631A2 (hu) 1,1- és 1,2-diszubtituált klórpropánszármazékok, eljárás előállításukra, és ilyen vegyületeket tartalmazó készítmények
RU2006101859A (ru) Замещенные дикетопиперазины и их использование в качестве антагонистов окситоцина
ES2083737T3 (es) 4-((2-benzotiazolil)metilamino)-alfa-((3,4-difluorofenoxi)metil)-1-piperidina-etanol.
NO176961C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-fenyl-5, 6-dihydrobenz[cÅakridin-7-karboksylsyrer og beslektede forbindelser
ATE69049T1 (de) Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives